ODI Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is July - June.

Millions SEK. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 11, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	55	35	110	84	82	68
Market Cap Growth	28.07%	-68.34%	30.91%	1.85%	21.08%	-20.36%
Enterprise Value	50	33	104	80	73	52
Last Close Price	2.98	2.18	7.20	5.50	5.40	4.46
PS Ratio	1.83	11.07	4.92	600.26	262.63	-
PB Ratio	30.52	81.70	54.76	32.54	8.87	4.17
P/TBV Ratio	30.52	81.70	54.76	32.54	8.87	4.17
EV/Sales Ratio	1.69	10.43	4.65	573.75	233.92	-
EV/EBITDA Ratio	-	-	240.49	-	-	-
EV/EBIT Ratio	-	-	242.14	-	-	-
Net Debt / Equity Ratio	-2.34	-3.49	-1.32	-2.52	-0.79	-0.90
Net Debt / EBITDA Ratio	-29.02	0.27	-6.13	0.95	1.02	3.70
Net Debt / FCF Ratio	-1.74	0.45	0.69	1.27	1.00	2.41
Asset Turnover	3.33	0.37	2.18	0.02	0.02	-
Inventory Turnover	-	-	-	0.77	0.34	-
Quick Ratio	1.15	0.71	1.14	1.30	6.84	26.74
Current Ratio	1.20	0.86	1.20	1.46	8.49	29.00
Return on Equity (ROE)	-27.54%	-489.19%	-24.84%	-116.63%	-56.64%	-21.89%
Return on Assets (ROA)	0.98%	-40.47%	2.62%	-45.57%	-32.91%	-13.13%
Return on Capital Employed (ROCE)	7.90%	-1283.70%	21.40%	-264.80%	-77.80%	-24.30%
Earnings Yield	-0.66%	-17.10%	-0.52%	-8.24%	-8.81%	-5.87%
FCF Yield	-	-9.53%	-3.49%	-6.10%	-8.98%	-8.93%
Buyback Yield / Dilution	-29.38%	-21.82%	0.76%	-1.69%	1.52%	-11.10%